ClinicalTrials.govpublic full text
Safety Study of Low Dose Interleukin 2 (IL-2) Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I
hepatitis c, interleukin-2, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908348
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.